NASDAQ:ATNF
180 Life Sciences Corp.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
180lifesciences.comipo date
Jun 27, 2017
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic C...Show More
Earnings
Earnings Release in 18 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus